Stock Research for ALXN

ALXN
Current Price

$118.9100


Latest Update: 2018-02-23 16:00:00

High
$ 118.9700
Low
$ 118.8500
Close
$ 118.9300
Volume
374307
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ALXN Stock Chart & Research Data

The ALXN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALXN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALXN Due diligence Resources & Stock Charts

The ALXN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALXN Detailed Price Forecast - CNN Money CNN View ALXN Detailed Summary - Google Finance
Yahoo View ALXN Detailed Summary - Yahoo! Finance Zacks View ALXN Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ALXN Trends & Analysis - Trade-Ideas Barrons View ALXN Major Holders - Barrons
NASDAQ View ALXN Call Transcripts - NASDAQ Seeking View ALXN Breaking News & Analysis - Seeking Alpha
Spotlight View ALXN Annual Report - CompanySpotlight.com OTC Report View ALXN OTC Short Report - OTCShortReport.com
TradeKing View ALXN Fundamentals - TradeKing Charts View ALXN SEC Filings - Bar Chart
WSJ View Historical Prices for ALXN - The WSJ Morningstar View Performance/Total Return for ALXN - Morningstar
MarketWatch View the Analyst Estimates for ALXN - MarketWatch CNBC View the Earnings History for ALXN - CNBC
StockMarketWatch View the ALXN Earnings - StockMarketWatch MacroAxis View ALXN Buy or Sell Recommendations - MacroAxis
Bullish View the ALXN Bullish Patterns - American Bulls Short Pains View ALXN Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ALXN Stock Mentions - StockTwits PennyStocks View ALXN Stock Mentions - PennyStockTweets
Twitter View ALXN Stock Mentions - Twitter Invest Hub View ALXN Investment Forum News - Investor Hub
Yahoo View ALXN Stock Mentions - Yahoo! Message Board Seeking Alpha View ALXN Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ALXN - SECform4.com Insider Cow View Insider Transactions for ALXN - Insider Cow
CNBC View ALXN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALXN - OTC Markets
Yahoo View Insider Transactions for ALXN - Yahoo! Finance NASDAQ View Institutional Holdings for ALXN - NASDAQ


Stock Charts

FinViz View ALXN Stock Insight & Charts - FinViz.com StockCharts View ALXN Investment Charts - StockCharts.com
BarChart View ALXN Stock Overview & Charts - BarChart Trading View View ALXN User Generated Charts - Trading View


Latest Financial News for ALXN

Report: Developing Opportunities within Jack In The Box, MedEquities Realty Trust, Fiesta Restaurant Group, Intuit, Alexion Pharmaceuticals, and Salesforce — Future Expectations, Projections Moving into 2018
Posted on Wednesday February 21, 2018

NEW YORK, Feb. 21, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Jack ...


See what the IHS Markit Score report has to say about Alexion Pharmaceuticals Inc.
Posted on Tuesday February 20, 2018

Alexion Pharmaceuticals Inc NASDAQ/NGS:ALXN


Inside Pfizer’s Rare Disease Segment Performance in 2017
Posted on Friday February 16, 2018

Pfizer’s 2017 Performance in Review


Alexion Pharmaceuticals Surged on February 14
Posted on Thursday February 15, 2018

How Did US Markets Perform on February 14?


Alexion Ups Its Game With ALXN1210 SC
Seeking Alpha - Feb 20, 2018
Alexion Pharmaceuticals (ALXN), a biopharmaceutical company which markets the blockbuster drug Soliris, is near the end of its journey to develop an even better version of Soliris called ALXN1210.
Alexion Pharmaceuticals Inc. (ALXN) Moves Lower on Volume Spike for February 19 - Equities.com

Alexion Pharmaceuticals - Appeal Increases, Not Pulling The Trigger Yet
Seeking Alpha - Feb 11, 2018
Alexion Pharmaceuticals (ALXN) is a great growth story within the biotechnology industry, having delivered on great returns for investors.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) – Early Moves to Watch - Nasdaq Journal
Alexion Pharmaceuticals, Inc. (ALXN) Analysts See $1.08 EPS - BZ Weekly

Alexion Pharmaceuticals Inc. (ALXN) Moves Lower on Volume Spike for February 16
Equities.com - Feb 16, 2018
Alexion Pharmaceuticals Inc. (ALXN) traded on unusually high volume on Feb. 16, as the stock lost 1.83% to close at $120.47.
Let's Take Some Time To Look Back: Alexion Pharmaceuticals, Inc. (ALXN ... - Post Analyst
Alexion Pharmaceuticals, Inc. (ALXN) EVP Sells $147864.86 in Stock - The Ledger Gazette

Alexion Pharmaceuticals Inc. Earnings Rise In Q4
Nasdaq - Feb 8, 2018
(RTTNews.com) - Alexion Pharmaceuticals Inc. ( ALXN ) revealed a profit for its fourth quarter that rose compared to the same period last year.

Enter a stock symbol to view the stock details.